Galván N Thao, Kumm Kayla, Kueht Michael, Ha Cindy P, Yoeli Dor, Cotton Ronald T, Rana Abbas, O'Mahony Christine A, Halff Glenn, Goss John A
Division of Abdominal Transplantation and Hepatobiliary Surgery, Baylor College of Medicine, 6620 Main Street, Suite 1425, Houston, TX 77030, USA.
University of Texas Health Science Center at San Antonio, UT Transplant Center, 4502 Medical Drive, San Antonio, TX 78229, USA.
J Transplant. 2018 Feb 18;2018:9739236. doi: 10.1155/2018/9739236. eCollection 2018.
Stress-induced heart failure, also known as Broken Heart Syndrome or Takotsubo Syndrome, is a phenomenon characterized as rare but well described in the literature, with increasing incidence. While more commonly associated with postmenopausal women with psychiatric disorders, this entity is found in the postoperative patient. The nonischemic cardiogenic shock manifests as biventricular failure with significant decreases in ejection fraction and cardiac function. In a review of over 3000 kidney and liver transplantations over the course of 17 years within two transplant centers, we describe a series of 7 patients with Takotsubo Syndrome after solid organ transplantation. Furthermore, we describe a novel approach of successfully treating the transient, though potentially fatal, cardiogenic shock with a percutaneous ventricular assistance device in two liver transplant patients, while treating one kidney transplant patient medically and the remaining four liver transplant patients with an intra-aortic balloon pump. We describe our experience with Takotsubo's Syndrome and compare the three modalities of treatment and cardiac augmentation. Our series is novel in introducing the percutaneous ventricular assist device as a more minimally invasive intervention in treating nonischemic heart failure in the solid organ transplant patient, while serving as a comprehensive overview of treatment modalities for stress-induced heart failure.
应激性心肌病,又称心碎综合征或Takotsubo综合征,是一种虽罕见但文献记载充分且发病率呈上升趋势的现象。虽然该病症更常见于患有精神疾病的绝经后女性,但也见于术后患者。非缺血性心源性休克表现为双心室衰竭,射血分数和心脏功能显著下降。在对两个移植中心17年间超过3000例肾脏和肝脏移植手术进行回顾时,我们描述了一系列7例实体器官移植术后发生Takotsubo综合征的患者。此外,我们描述了一种新方法,即使用经皮心室辅助装置成功治疗两例肝移植患者短暂但可能致命的心源性休克,同时对一例肾移植患者进行药物治疗,对其余四例肝移植患者使用主动脉内球囊泵治疗。我们介绍了我们在Takotsubo综合征方面的经验,并比较了三种治疗方式和心脏增强方法。我们的系列研究具有创新性,将经皮心室辅助装置作为治疗实体器官移植患者非缺血性心力衰竭的一种微创性更高的干预措施,同时对应激性心肌病的治疗方式进行了全面概述。